AlzeCure Pharma AB (publ) (FRA:AC6)
Germany · Delayed Price · Currency is EUR 0.1520
0.00 (0.00%)
Last updated: Jan 28, 2026, 8:15 AM CET
AlzeCure Pharma AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
21.00M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdCapital AG | 157.83M |
| ACCENTRO Real Estate AG | 77.32M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.26M |
| tick Trading Software AG | 9.08M |
| Consensus Asset Management AB | 5.69M |
| Weng Fine Art AG | 2.48M |
| Rubean AG | 1.78M |
| Petro Matad | 1.73M |